1. Home
  2. NRG vs ONC Comparison

NRG vs ONC Comparison

Compare NRG & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NRG Energy Inc.

NRG

NRG Energy Inc.

HOLD

Current Price

$154.66

Market Cap

28.9B

Sector

Utilities

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$297.15

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRG
ONC
Founded
1989
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
31.4B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NRG
ONC
Price
$154.66
$297.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
10
Target Price
$203.00
$385.10
AVG Volume (30 Days)
2.3M
178.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.27%
N/A
EPS Growth
N/A
N/A
EPS
4.01
N/A
Revenue
$30,713,000,000.00
N/A
Revenue This Year
$14.46
$723.76
Revenue Next Year
$3.12
$15.04
P/E Ratio
$38.27
$614.06
Revenue Growth
9.18
N/A
52 Week Low
$114.20
$228.93
52 Week High
$189.96
$385.22

Technical Indicators

Market Signals
Indicator
NRG
ONC
Relative Strength Index (RSI) 47.34 45.12
Support Level $143.49 $283.56
Resistance Level $159.91 $300.00
Average True Range (ATR) 5.94 6.45
MACD -0.74 -1.76
Stochastic Oscillator 24.41 20.73

Price Performance

Historical Comparison
NRG
ONC

About NRG NRG Energy Inc.

NRG Energy is one of the largest retail energy providers in the US, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home-services customers. NRG also is one of the largest US independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. The LS Power asset acquisition adds 13 GW of gas-fired power plants mostly in the Eastern US. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: